Institutions / DAFNA Capital Management LLC / Holdings
Back to DAFNA Capital Management LLC

DAFNA Capital Management LLC

All holdings · as of Mar 31, 2026

83 positions

CompanyClassValueShares% of portfolio
Aquestive Therapeutics, Inc.AQSTCommon Stock$1.53M368,4150.3%
MEDIWOUND LTD—$1.52M94,4050.3%
ORTHOPEDIATRICS CORPKIDSCommon Stock$1.52M95,6590.3%
Ultragenyx Pharmaceutical Inc.—$1.28M61,1000.3%
enGene Therapeutics Inc.—$1.28M187,3530.3%
Neurogene Inc.NGNECommon Stock$1.14M56,6350.3%
ARS Pharmaceuticals, Inc.—$1.12M139,2850.3%
CytomX Therapeutics, Inc.—$1.08M230,0000.2%
Maze Therapeutics, Inc.—$1.04M35,0000.2%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$1.04M38,4900.2%
SCYNEXIS, Inc.—$996.6K1,086,9560.2%
Oric Pharmaceuticals, Inc.—$945.5K98,7240.2%
Inspire Medical Systems, Inc.—$938.8K18,2000.2%
POLYPID LTD—$910.6K207,9000.2%
TELA Bio, Inc.—$893.4K1,441,0290.2%
Zenas BioPharma, Inc.ZBIOCommon Stock$830.9K42,5000.2%
Verrica Pharmaceuticals Inc.VRCACommon Stock$813.1K153,7120.2%
FATE THERAPEUTICS INC—$660.0K550,0000.2%
Annexon, Inc.—$652.7K117,8120.1%
ACCURAY INC—$652.2K1,680,5080.1%
NEWAMSTERDAM PHARMA CO—$640.2K20,0000.1%
Adicet Bio, Inc.—$638.9K93,8120.1%
BioNTech SEBNTXADR$622.2K7,0000.1%
PLIANT THERAPEUTICS, INC.PLRXCommon Stock$613.6K487,0000.1%
COMPUGEN LTD—$549.1K257,7830.1%
Orchestra BioMed Holdings, Inc.OBIOCommon Stock$539.1K126,8410.1%
Foghorn Therapeutics Inc.—$534.7K111,8590.1%
iBio, Inc.IBIOCommon Stock$367.9K193,6380.1%
Bicycle Therapeutics plcBCYCADR$299.2K64,4920.1%
ADC THERAPEUTICS SA—$270.3K72,0810.1%
Karyopharm Therapeutics Inc.—$255.1K45,8000.1%
Autolus Therapeutics plcAUTLADR$247.5K179,3160.1%
Neumora Therapeutics, Inc.NMRACommon Stock$136.5K70,0000.0%
← PrevPage 2 of 2Next →